0 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers

Dietary Supplement: Dihydrocapsiate

Kellogg's ready to eat cereal, cereal bars, and crackers will contain dihyrocapsiate or placebo. Daily consumption of dihydrocapsiate is 9mg/d or 0mg/d.

Other Name: Natural substances present in sweet chili peppers

Active Comparator: Dihydrocapsiate 9 mg/d

9 mg/d of Dihydrocapsiate will be consumed in ready to ear cereal, cereal bars or crackers

Dietary Supplement: Dihydrocapsiate

Kellogg's ready to eat cereal, cereal bars, and crackers will contain dihyrocapsiate or placebo. Daily consumption of dihydrocapsiate is 9mg/d or 0mg/d.

Other Name: Natural substances present in sweet chili peppers

Detailed Description:

Capsaicin, a substance found in chili pepper, is known to stimulate thermogenesis. Dihydrocapsiate, a capsinoid, found in the non-pungent CH-19 sweet pepper has similar thermogenic effects without the gastrointestinal side effects. The objective of this project is to test the effect of 12 weeks of daily consumption of 9 mg dihydrocapsiate on resting energy expenditure relative to baseline when compared to a control group consuming products without DCT.

Eligibility

Ages Eligible for Study:

25 Years to 45 Years

Genders Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

BMI: 18.5-34.5 kg/m2

Good general health

Low to mild physical activity

Willing to maintain habitual diet and physical activity patterns throughout the study period

Premenopausal and cycling regularly or using oral contraceptives

Willing to attend study visits only during the follicular phase or bleed phase of their menstrual cycle

Unwilling to be randomized to any experimental group and unable to meet all requirements of the study

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01773356